formulations

Gufic Biosciences (NSE – GUFICBIO) – Nov’21 Alpha/Alpha plus stock

Dear Members, We have released 30th Nov’21: Gufic Biosciences Ltd (NSE Code – GUFICBIO) – Alpha/Alpha Plus stock for Nov’21. For details and other updates, please log into the website at the following link – https://katalystwealth.com/index.php/my-account/ Note: For any queries, mail us at [email protected] Date: 30th Nov’21 CMP – 182.25 (BSE); 181.60 (NSE)                                                            Face Value – 1.00 Rating – Positive – 4% weightage (refer rating interpretation)   Introduction Gufic Biosciences Limited (GUFIC) was incorporated in the year 2000 as a public limited company…

Read More

6th Nov’20 – Sep’20 earnings update on Suven Pharma and Can Fin Homes

Dear Members, We have released 6th Nov’20 – Sep’20 earnings update on Suven Pharmaceuticals and Can Fin Homes. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 6th Nov’20   Suven Pharmaceuticals (NSE – SUVENPHAR) – May’17 Alpha stock CMP – 325.75 (BSE); 326.60 (NSE) Rating – Positive – 5% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Suven Pharmaceuticals got demerged from Suven Lifesciences with the entire revenue generating businesses consisting of CRAMS,…

Read More
Copy Protected by Chetan's WP-Copyprotect.